CMS released a broad-ranging proposed rule for the Medicare Advantage and Part D Programs on Thursday, November 16, 2017. The proposed rule addresses a broad and diverse range of MA and Part D regulatory requirements, affecting not only Medicare Advantage Organizations and Part D Sponsors, but also health care providers, pharmacies, pharmaceutical manufacturers and others.
CMS Releases Broad-Ranging Medicare Advantage and Part D Proposed Rule
Posted In Employee Benefits, Health and Welfare Plans
Tags: 21st Century Cures Act, 42 CFR § 423.505(b)(18), Any Willing Pharmacy provisions, AWP, Centers for Medicare & Medicaid Services (CMS), Comprehensive Addiction and Recovery Act of 2016, Medical Loss Ratios, Medicare Advantage, Medicare marketing guidelines, MLR, Part D AWP, Part D Programs, pharmacy rebates, plan sponsors, Proposed Rule, Section 1860D-4(b)(1)(A) of the Social Security Act, Star Ratings

Ankur J. Goel represents health industry clients in significant compliance, False Claims Act, litigation and regulatory matters. Ankur works with a range of health industry clients. He represents health plans on issues arising under Medicare Advantage, Part D, and health insurance exchanges, as well as health care providers on a variety of complex enforcement, compliance, regulatory and litigation matters. Read Ankur Goel's full bio.

Kate McDonald focuses her practice on transactional and regulatory counseling for clients in the health care industry, with particular focus on federal and state health care government programs and the intersection between health care payors and providers. Kate regularly advises health insurers, health maintenance organizations (HMOs), health care government contractors, health care providers and other clients on compliance with health care laws and regulations, particularly in connection with Medicare Advantage, Medicare Part D, Medicaid managed care, the Affordable Care Act, state insurance laws, and state licensure and professional practice regulations. Read Kate McDonald's full bio.

Lauren E. Parisi focuses her practice on health advisory matters. Lauren has provided strategic counseling on federal and state legislation, regulations and sub-regulatory guidance related to the Affordable Care Act. She has experience tracking, analyzing and summarizing new regulatory developments related to federal health care reform. Lauren has also represented various clients in civil litigation, arbitration and government investigations. Read Lauren Parisi's full bio.
Related Posts
- Pharmacy Benefit Manager Reform: What’s on the Horizon?
- Tenth Circuit Reaffirms Preemption of State Pharmacy Network Regulations
- HHS OIG Develops Toolkit to Analyze Telehealth Claims to Assess Program Integrity Risks
- Medicare Advantage Plan Requirements Post-PHE: Ensuring a Smooth Transition
- Preparing for the End of the COVID-19 Emergency: Deadline Tolling
BLOG EDITORS
STAY CONNECTED
TOPICS
ARCHIVES
RECENT POSTS
- The Proposed MHPAEA Regulations: Comments on Behavioral Health Carve-Out Vendors
- California’s New Reproductive Privacy Laws Create Information-Sharing Complexities
- California Wage Law Puts ‘Band-Aids’ on Healthcare Worker Shortages
- Doctors Question Medicare Quality Program as More Face Steeper Penalties
- Surprise Billing Arbitration Is Still a Mess

